Isoardo GL - Search Results

1

Autoimmune events during interferon beta-1b treatment for multiple sclerosis.

Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, Gentile E, Isoardo GL, Ricci A, Rota E, Bergamasco B, Durazzo M, Saracco G, Biava MA, Brossa PC, Giorda L, Pagni R, Aimo G. Durelli L, et al. Among authors: isoardo gl. J Neurol Sci. 1999 Jan 1;162(1):74-83. doi: 10.1016/s0022-510x(98)00299-8. J Neurol Sci. 1999. PMID: 10064173 Clinical Trial.

2

Does high-dose interferon beta-1b improve clinical response in more severely disabled multiple sclerosis patients?

Durelli L, Oggero A, Verdun E, Isoardo G, Ricci A, Barbero P, Bergamasco B. Durelli L, et al. J Neurol Sci. 2000 Sep 1;178(1):37-41. doi: 10.1016/s0022-510x(00)00361-0. J Neurol Sci. 2000. PMID: 11018247 Clinical Trial.

3

Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy.

Isoardo G, Ferrero B, Barbero P, Cucci A, Oggero A, Pipieri A, Ricci A, Verdun E, Bergamasco B, Durelli L. Isoardo G, et al. Acta Neurol Scand. 2001 Mar;103(3):180-7. doi: 10.1034/j.1600-0404.2001.103003180.x. Acta Neurol Scand. 2001. PMID: 11240566

4

Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody.

Cocito D, Isoardo G, Ciaramitaro P, Migliaretti G, Pipieri A, Barbero P, Cucci A, Durelli L. Cocito D, et al. Muscle Nerve. 2001 Oct;24(10):1278-82. doi: 10.1002/mus.1145. Muscle Nerve. 2001. PMID: 11562906

5

Interferon-beta dose and efficacy: the OPTIMS study.

Durelli L, Oggero A, Verdun E, Barbero P, Pipieri A, Isoardo G, Ricci A, Clerico M, Bradac G, Bergamasco B, Bergui M. Durelli L, et al. Neurol Sci. 2001 Apr;22(2):201-3. doi: 10.1007/s100720170024. Neurol Sci. 2001. PMID: 11603627

6

Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study.

Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, Bergamasco B, Brossa PC, Ghigo E, Maccario M, Faggiano F; Betaferon Safety Trial (BEST) Study Group. Durelli L, et al. Among authors: isoardo gl. J Neurol Sci. 2001 Dec 15;193(1):17-22. doi: 10.1016/s0022-510x(01)00637-2. J Neurol Sci. 2001. PMID: 11718745

7

Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?

Verdun E, Isoardo G, Oggero A, Ferrero B, Ghezzi A, Montanari E, Zaffaroni M, Durelli L; Betaferon Safety Trial (BEST) Study Group. Verdun E, et al. J Interferon Cytokine Res. 2002 Feb;22(2):245-55. doi: 10.1089/107999002753536220. J Interferon Cytokine Res. 2002. PMID: 11911808

8

High-dose intravenous immunoglobulin treatment of multiple sclerosis.

Durelli L, Isoardo G. Durelli L, et al. Neurol Sci. 2002 Apr;23 Suppl 1:S39-48. doi: 10.1007/s100720200014. Neurol Sci. 2002. PMID: 12032586 Review.

9

Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.

Cocito D, Ciaramitaro P, Isoardo G, Barbero P, Migliaretti G, Pipieri A, Proto G, Quadri R, Bergamasco B, Durelli L. Cocito D, et al. J Neurol. 2002 Jun;249(6):719-22. doi: 10.1007/s00415-002-0698-0. J Neurol. 2002. PMID: 12111305

10

Intracranial stimulation of the facial nerve: normative values with magnetic coil in 240 nerves.

Cocito D, Isoardo G, Migliaretti G, Ciaramitaro P, Rota E, Poglio F, Bergamasco B. Cocito D, et al. Neurol Sci. 2003 Feb;23(6):307-11. doi: 10.1007/s100720300006. Neurol Sci. 2003. PMID: 12624718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters